The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4
Conditions: CKD Stage 3b; CKD Stage 4 Intervention: Drug: Sevelamer Carbonate Sponsor: Fan Fan Hou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 24, 2018 Category: Research Source Type: clinical trials
Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
Condition: Hyperphosphatemia Interventions: Drug: Placebo; Drug: Sevelamer Carbonate (GZ419831) Sponsor: Sanofi Not yet recruiting - verified December 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2016 Category: Research Source Type: clinical trials
A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
Condition: Hyperphosphatemia Interventions: Drug: EOS789; Drug: Placebo; Drug: Renvela Sponsor: Chugai Pharmaceutical Not yet recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 11, 2016 Category: Research Source Type: clinical trials
A Prospective, Single-center, Randomized, Controlled Study of Sevelamer Carbonate in the Lipid Metabolism and Uric Acid Treatment of Obesity-Related Glomerulopathy
Condition: Obesity and GlomerulopathyInterventions: Drug: High dosage Sevelamer Carbonate + Irbesartan; Drug: Low dosage Sevelamer Carbonate + Irbesartan; Drug: IrbesartanSponsor: Zhi-Hong Liu, M.D.Not yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2015 Category: Research Source Type: clinical trials
An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD Patients
Condition: Renal Failure ChronicInterventions: Drug: sevelamer carbonate 800mg; Drug: sevelamer carbonate 2.4 gSponsor: Genzyme, a Sanofi CompanyCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2014 Category: Research Source Type: clinical trials
A Phase 1 Study to Examine the Effect of Renvela on the Pharmacodynamics of AZD1722
Condition: HealthyInterventions: Drug: AZD1722; Drug: RenvelaSponsors: Ardelyx; AstraZenecaCompleted - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2014 Category: Research Source Type: clinical trials
